Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,660.00    -30.00 (-0.53%)
Bid:
5,640.00
Ask:
5,660.00
Spread: 20.00 (0.355%)
Market Cap: £3.03b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

CMD and upgraded medium term targets

20 Mar 2025 07:00

RNS Number : 3755B
Cranswick PLC
20 March 2025
 

20 March 2025

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Capital Markets Day and upgraded medium term targets

 

Cranswick, a leading UK food producer, is today hosting a Capital Markets Day in London for analysts and institutional investors.

 

Presented by a selection of the Group's senior leaders, the event will provide an update on the Group's strategy, its successful compounding track record and how key strategic enablers will drive further growth.

 

Today's event will cover the following:

 

· Securing pig supply, driving competitive advantage and leveraging genetics capability

· Investing in fresh pork processing to add capacity and enhance automation

· Maximising the fresh poultry supply chain opportunity and growing poultry processing capacity

· Differentiated product portfolio and further premiumisation

· Strength and depth of customer relationships, including new long-term agreements

 

We will also outline upgraded medium term targets reflecting strengthening returns from disciplined capital allocation, as follows:

 

· Mid single digit organic revenue growth1

· ~7.5% adjusted operating margin2, increased from >6%

· Mid single digit adjusted EPS growth2 maintained

· Upper teens ROCE3, increased from mid-teens

· 4 maintained

· 90% free cash conversion5 maintained

 

For those unable to attend in person, a copy of the presentation and an audio recording will be made available after the event at www.cranswick.plc.uk.

 

Outlook

Robust demand for our core pork and poultry products has continued through the fourth quarter. The outlook for the current financial year ending 29 March 2025 remains in line with current market expectations6. No further material commentary on current trading and outlook will be provided at today's event.

 

Preliminary results

The Company's preliminary results announcement for the 52 weeks ending 29 March 2025 will be released on Tuesday 20 May 2025.

 

Adam Couch, CEO of Cranswick, commented:

"2025 marks Cranswick's 50th anniversary and today's Capital Markets Day event is a fantastic opportunity to reflect on our successful business model and strategy which have delivered strong, compound returns for our shareholders and compelling future growth opportunities.

 

"We are also announcing today more ambitious medium-term financial targets, reflecting the significant strategic progress we have made since first introducing these measures.

 

"Our relentless focus on the strengths of the business, which include industry leading investment, a clearly defined strategy, broadening product portfolio and unrivalled management team, will continue to support the future successful development of Cranswick over the long term."

 

 

1

2

3

 

4

5

 

6

Excludes the impact of M&A.

Excludes IAS 41 movement on biological assets, acquisition related amortisation and impairment of intangible assets.

Adjusted operating profit divided by the sum of average opening and closing net assets, net debt, pension surplus and deferred tax.

Net debt (including IFRS 16) divided by adjusted EBITDA.

Defined as the sum of net cash from operating activities less interest paid, non-growth capital expenditure, net IAS 41 valuation, lease capital and lease interest divided by adjusted profit for the year.

Market expectations for adjusted profit before tax as at 20 March 2025 range between £190.0m and £195.1m. The range reflects all published Broker analysis.

 

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Sodali & Co

+44 207 100 6451

Ben Foster / Louisa Henry / Flora Mackenzie

cranswick@sodali.com

 

 

Note to editors:

1. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 15,000 people and operates from 22 well-invested, highly efficient facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 53 weeks to 30 March 2024 showed revenue of £2,599.3m and profit before tax of £158.4m. For more information go to: www.cranswick.plc.uk

2. At Cranswick, it is second nature for us to protect and nurture our environment while supporting people and communities to thrive. Guided by our sustainability strategy, Second Nature, we have seamlessly integrated our sustainability commitments into the core of our business model, which in turn shapes our decision-making, culture, and actions. For more information on out Second Nature strategy, please visit: www.cranswick.plc.uk/sustainability

3. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPDNFESSEFA
Date   Source Headline
15th Jul 20163:23 pmRNSHolding(s) in Company
14th Jul 20163:13 pmRNSHolding(s) in Company
7th Jul 20164:27 pmRNSDividend Declaration
1st Jul 20163:23 pmRNSDirector/PDMR Shareholding
1st Jul 20169:17 amRNSTotal Voting Rights
21st Jun 20164:51 pmRNSDirector/PDMR Shareholding
6th Jun 20162:09 pmRNSTotal Voting Rights
26th May 20169:14 amRNSDirector Declaration
24th May 20167:00 amRNSFinal Results
18th May 20163:14 pmRNSHolding(s) in Company
4th May 20169:23 amRNSAdditional Listing
11th Apr 20167:00 amRNSAcquisition of leading integrated poultry business
5th Apr 20167:00 amRNSTrading Statement
1st Apr 20164:53 pmRNSBlocklisting Interim Review
1st Apr 20164:47 pmRNSBlocklisting Interim Review
1st Apr 201611:23 amRNSTotal Voting Rights
18th Mar 20164:44 pmRNSDirector/PDMR Shareholding
18th Mar 20164:22 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:30 pmRNSDirector/PDMR Shareholding
26th Feb 20163:04 pmRNSDirector/PDMR Shareholding
26th Feb 201610:08 amRNSDirector Declaration
2nd Feb 20169:23 amRNSDirector/PDMR Shareholding
1st Feb 201611:45 amRNSDirector/PDMR Shareholding
1st Feb 201611:44 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSTrading Statement
27th Jan 201611:44 amRNSAdditional Listing
17th Dec 20152:44 pmRNSDividend Declaration
14th Dec 20155:38 pmRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSHalf Yearly Report
5th Oct 201510:38 amRNSBlocklisting Interim Review
5th Oct 201510:37 amRNSBlocklisting Interim Review
1st Oct 20154:13 pmRNSTotal Voting Rights
1st Oct 20157:00 amRNSFirst Half Trading Statement
28th Sep 201511:03 amRNSDirector Declaration
8th Sep 20154:56 pmRNSDirector/PDMR Shareholding
8th Sep 20154:53 pmRNSDirector/PDMR Shareholding
8th Sep 20154:51 pmRNSDirector/PDMR Shareholding
1st Sep 20151:45 pmRNSAdditional Listing
10th Aug 20154:06 pmRNSDirector/PDMR Shareholding
5th Aug 20154:18 pmRNSTR-1: Notification of Major Interest in Shares
3rd Aug 20156:19 pmRNSTotal Voting Rights
28th Jul 201511:56 amRNSResult of AGM
27th Jul 20157:00 amRNSInterim Management Statement
13th Jul 20156:17 pmRNSDividend Declaration
15th Jun 20155:47 pmRNSDirector/PDMR Shareholding
4th Jun 20158:21 amRNSTotal Voting Rights
19th May 20157:00 amRNSDirector Declaration
18th May 20157:00 amRNSFinal Results
9th Apr 20157:00 amRNSFourth Quarter Trading Statement
7th Apr 20159:22 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.